Advertisement



More in Pharmacy

Mounjaro (tirzepatide), Eli Lilly's Type 2 diabetes drug, helped obese and overweight adults lose an average of 64 pounds after 84 weeks in a phase 3 trial. 

When Pfizer's antiviral Paxlovid entered the U.S. market in December 2021, it quickly became the preferred COVID-19 drug. Nearly two years later, physicians aren't writing many prescriptions for the therapy once touted as a "breakthrough," NBC News reported. 

Danielle Griggs, PharmD, will be the chief pharmacy officer of Charlottesville, Va.-based UVA Health, effective Oct. 18. 

Advertisement
Advertisement
Advertisement